JAN 02, 2016 03:53 PM PST

HER2-Targeted Vaccine for Breast Cancer

WRITTEN BY: Kara Marker
A vaccine for cancer? The HER2-targeted vaccine could prevent the recurrence of HER2-postive breast cancers by boosting the T cell response to these specific tumor cells.

In a new study from the Perelman School of Medicine at the University of Pennsylvania, scientists noticed that patients whose HER2-positive breast cancer had recurred showed a much weaker T cell response than patients still in remission to HER2 (human epidermal growth factor receptor 2), a gene that is overexpressed and causes uncontrolled cell growth in 25 percent of breast cancers (BreastCancer.org). Their results were published in JAMA Oncology this week.

"The thinking is that the patient's anti-HER2 T cells somehow become exhausted and die or otherwise stop responding," said Brian J. Czerniecki, MD, PhD, and senior author of the study. "We're trying to determine the mechanism, but we already know that we can 'fill the tank' with vaccines to restore that specific responsivity to HER2."

Czerniecki’s “fill the tank” notion comes from revitalizing T cell ability to recruit killer lymphocytes to attack growing tumor cells with stimulatory vaccines. HER2-positive breast cancers are not the only abnormally growing cells to inhibit the immune system in order to evade detection or attack.

To test the ability of immune cells from cancer patients with recurrent HER2-positive breast cancer with the cells of patients still in remission, Czerniecki and his team observed in vivo the T cell response of 95 isolated immune cells when HER2 is injected. Results showed the recurrent cancer patients’ T cells “had only about a tenth of the anti-HER2 responsivity” compared to the T cells of patients whose cancer had not returned.

The team from the University of Pennsylvania is continuing studies on the change in immune response to HER2 over time as well as doing clinical trials with a HER2-targeted vaccine.

To learn more about how HER2 can promote cancer cell growth, watch the following video.
Source: University of Pennsylvania
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 20, 2019
Immunology
SEP 20, 2019
Decipher the Clues with CRISPR
Scientists have created the first retroviral CRISPR-Cas9 gene editing library to explore the regulation of mouse T cells, which are key cells in the immune system. Researchers mapped the most...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Combination Therapeutic Effective for Leishmaniasis and HIV Patients
In a study published in PLOS Neglected Diseases, a special combination therapy has been proven for efficacy in cases of coinfection with Visceral leishmani...
SEP 20, 2019
Immunology
SEP 20, 2019
High Res Look Into the Brain of MS
Researchers have revealed a subtype of immune cell aiding in the autoimmune disorder Multiple Sclerosis...
SEP 20, 2019
Immunology
SEP 20, 2019
A New Alzheimer's Villain
Researchers show, for the first time, that a blood-clotting protein called fibrinogen is responsible for a series of molecular and cellular events that can destroy connections between neurons...
SEP 20, 2019
Immunology
SEP 20, 2019
Why Does My Throat Hurt Again
Scientists are uncovering the mechanisms behind recurring cases of step throat...
SEP 20, 2019
Immunology
SEP 20, 2019
Dengue Meet Immune System
A physical interaction between two types of immune cells that plays an essential role in the early fight against dengue virus infection has been observed for the first time....
Loading Comments...